Targeting CD24 in Cancer Immunotherapy

Immunotherapy is a hot area in cancer treatment, and one of the keys to this therapy is the identification of the right tumour-associated or tumour-specific antigen. Cluster of differentiation 24 (CD24) is an emerging tumour-associated antigen that is commonly and highly expressed in various tumours...

Full description

Bibliographic Details
Published in:	Biomedicines
Main Authors:	Wenwen Chen, Zhigang Hu, Zhigang Guo
Format:	Article
Language:	English
Published:	MDPI AG 2023-11-01
Subjects:	CD24 siglec-10 immunotherapy
Online Access:	https://www.mdpi.com/2227-9059/11/12/3159

Similar Items

Checkpoint CD24 function on tumor and immunotherapy
by: Shiming Huang, et al.
Published: (2024-02-01)

Targeting the CD24-Siglec10 Axis: A Potential Strategy for Cancer Immunotherapy
by: Junyue Fang, et al.
Published: (2024-02-01)

The biological roles of CD24 in ovarian cancer: old story, but new tales
by: Yuanyuan Gu, et al.
Published: (2023-06-01)

Molecular Mechanism of Tumor Cell Immune Escape Mediated by CD24/Siglec-10
by: Shan-Shan Yin, et al.
Published: (2020-07-01)

Siglec‐G Suppresses CD8+ T Cells Responses through Metabolic Rewiring and Can be Targeted to Enhance Tumor Immunotherapy
by: Shenhui Yin, et al.
Published: (2024-12-01)

Ultrasound nanodroplets loaded with Siglec-G siRNA and Fe3O4 activate macrophages and enhance phagocytosis for immunotherapy of triple-negative breast cancer
by: Ci Yin, et al.
Published: (2024-12-01)

Targeting CD24 as a novel immunotherapy for solid cancers
by: Yan Yang, et al.
Published: (2023-11-01)

Editorial: CD24 in the regulation of cellular development and disease
by: Sherri L. Christian, et al.
Published: (2024-02-01)

CD33 as a leukocyte-associated marker expressed on human spermatozoa
by: Nasrin Sereshki, et al.
Published: (2023-04-01)

CD24 May Serve as an Immunotherapy Target in Triple-Negative Breast Cancer by Regulating the Expression of PD-L1
by: Zhu X, et al.
Published: (2023-12-01)

Recent progress in targeting the sialylated glycan-SIGLEC axis in cancer immunotherapy
by: Yingyan Yu, et al.
Published: (2023-05-01)

Does SIGLEC8 localize to the subcellular compartment like the Alzheimer's disease protective CD33 splice variant?
by: Chirag Dhar
Published: (2023-04-01)

CD24 Is a Potential Immunotherapeutic Target for Mantle Cell Lymphoma
by: Jimena Álvarez Freile, et al.
Published: (2022-05-01)

Plasma Siglec-5 and CD163 as Novel Biomarkers for Fulminant Myocarditis
by: Yan Zhuang, et al.
Published: (2022-11-01)

Siglecs as Therapeutic Targets in Cancer
by: Jackwee Lim, et al.
Published: (2021-11-01)

Dual blockade of CD47 and CD24 signaling using a novel bispecific antibody fusion protein enhances macrophage immunotherapy
by: Yun Yang, et al.
Published: (2023-12-01)

Vinburnine potentiates anti-PD1 immunotherapy in melanoma through IL-24 secretion via P38/MAPK/ATF3 signaling
by: Susi Zhu, et al.
Published: (2025-08-01)

The safety and potential efficacy of exosomes overexpressing CD24 (EXO-CD24) in mild-moderate COVID-19 related ARDS
by: Ioannis Grigoropoulos, et al.
Published: (2024-04-01)

Comparison of Protein and Peptide Targeting for the Development of a CD169-Based Vaccination Strategy Against Melanoma
by: Dieke van Dinther, et al.
Published: (2018-09-01)

Tolerogenic Immunotherapy: Targeting DC Surface Receptors to Induce Antigen-Specific Tolerance
by: Charlotte Castenmiller, et al.
Published: (2021-02-01)

CD44/CD24 Expression in recurrent gastric cancer: a retrospective analysis
by: Yong Ching-Shya, et al.
Published: (2012-07-01)

Sugar Free: Novel Immunotherapeutic Approaches Targeting Siglecs and Sialic Acids to Enhance Natural Killer Cell Cytotoxicity Against Cancer
by: John Daly, et al.
Published: (2019-05-01)

Targeting cancer-associated glycans as a therapeutic strategy in leukemia
by: Ashraf Abdullah Saad
Published: (2022-12-01)

Expression of CD133 and CD24 and their different phenotypes in urinary bladder carcinoma
by: Farid RM, et al.
Published: (2019-05-01)

miR-155 Regulates IL-10-Producing CD24hiCD27+ B Cells and Impairs Their Function in Patients with Crohn’s Disease
by: Yingxia Zheng, et al.
Published: (2017-08-01)

Systemic lupus erythematous and CD24V
by: Rubén Darío Jiménez-Uscanga, et al.
Published: (2015-11-01)

Inhaled Exosomes Genetically Manipulated to Overexpress CD24 (EXO-CD24) as a Compassionate Use in Severe ARDS Patients
by: Orr Green, et al.
Published: (2023-09-01)

Functional CD169 on Macrophages Mediates Interaction with Dendritic Cells for CD8+ T Cell Cross-Priming
by: Dieke van Dinther, et al.
Published: (2018-02-01)

The expression characteristic and prognostic role of Siglec‐15 in lung adenocarcinoma
by: Haijun Sun, et al.
Published: (2024-05-01)

Treatment with soluble CD24 attenuates COVID-19-associated systemic immunopathology
by: No-Joon Song, et al.
Published: (2022-01-01)

Tumor-associated macrophages: untapped molecular targets to improve T cell-based immunotherapy
by: Rui M. L. Coelho, et al.
Published: (2025-10-01)

Phenotypic Characterization by Single-Cell Mass Cytometry of Human Intrahepatic and Peripheral NK Cells in Patients with Hepatocellular Carcinoma
by: Yuichi Yoshida, et al.
Published: (2021-06-01)

A novel platform for attenuating immune hyperactivity using EXO‐CD24 in COVID‐19 and beyond
by: Shiran Shapira, et al.
Published: (2022-07-01)

Exploring CD169<sup>+</sup> Macrophages as Key Targets for Vaccination and Therapeutic Interventions
by: Rianne G. Bouma, et al.
Published: (2025-03-01)

CD69 is a Promising Immunotherapy and Prognosis Prediction Target in Cancer
by: Li Y, et al.
Published: (2024-01-01)

Predicting ovarian cancer prognosis and immunotherapy response through siglec15 and PD-L1 expression analysis
by: Aiyue Zhao, et al.
Published: (2025-12-01)

Integrative Analysis of the Expression of SIGLEC Family Members in Lung Adenocarcinoma via Data Mining
by: Haiyan Zhang, et al.
Published: (2021-03-01)

Surprising magic of CD24 beyond cancer
by: He Wang, et al.
Published: (2024-01-01)

Evasion of immunosurveillance by the upregulation of Siglec15 in bladder cancer
by: Dingshan Deng, et al.
Published: (2024-11-01)

3E10 Targeting CD24 Enhances Chemotherapy Sensitivity of Hepatocellular Carcinoma HuH-7 Cells
by: HUANG Zejian, et al.
Published: (2018-08-01)